In cancer cells, IL-24 exerts its biological effects also via non-canonical JAK/STAT pathway activation through interaction with other intracellular molecular partners, including endoplasmic reticulum (ER)–resident chaperone BiP/GRP78 and dsRNA-activated protein kinase (PKR) [43]. Here, IL24 is linked to cancer.